BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.
NCT03495050 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2018-06-12
Summary
Prospective non interventional, observational registry of 150 patients undergoing TAVI with Evolut platform for bicuspid aortic stenosis.
Conditions
- Bicuspid Aortic Valve
Interventions
- DEVICE
-
Transcatheter Aortic Valve Implantation
Transcatheter treatment of bicuspid aortic stenosis with the Evolut Pro/XL platform
Sponsors & Collaborators
-
Clinique Pasteur
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-21
- Primary Completion
- 2019-05-31
- Completion
- 2020-05-31
- FDA Device
- Yes
Countries
- France
Study Locations
More Related Trials
-
EDWARDS INTUITY Valve System CADENCE Study
NCT02688153 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis
NCT07116551 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve
NCT03225001 ·Status: COMPLETED ·Phase: NA
-
Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)
NCT05454150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Performance and Safety of the Lotus™ Valve With a FLEXible Delivery System
NCT03043404 ·Status: COMPLETED ·Phase: NA
-
Colibri Transcatheter Aortic Heart Valve System Study
NCT04029844 ·Status: RECRUITING ·Phase: NA
-
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B
NCT02184442 ·Status: COMPLETED ·Phase: NA
-
THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial
NCT00530894 ·Status: COMPLETED ·Phase: NA
-
REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System
NCT01627691 ·Status: COMPLETED ·Phase: NA
-
Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
NCT04843072 ·Status: RECRUITING ·Phase: NA
-
CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat Patients With Severe Aortic Stenosis.
NCT03752866 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate the Safety and Efficacy of the Apica Access, Stabilization and Closure (ASC™) Device
NCT01721642 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SOURCE XT REGISTRY
NCT01238497 ·Status: COMPLETED
-
French Registry Conducted on E-vita OPEN NEO
NCT05721001 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies
NCT05479305 ·Status: RECRUITING ·Phase: NA
-
FlexNav EU CE Mark Study
NCT03724812 ·Status: COMPLETED ·Phase: NA
-
REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm
NCT01383720 ·Status: COMPLETED ·Phase: NA
-
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
NCT05862558 ·Status: RECRUITING
-
Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis
NCT05804903 ·Status: SUSPENDED ·Phase: NA
-
Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.
NCT06470022 ·Status: RECRUITING ·Phase: NA
-
Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)
NCT01775046 ·Status: COMPLETED
-
EVA3S: Endarterectomy Versus Angioplasty in Patients With Severe Symptomatic Carotid Stenosis
NCT00190398 ·Status: COMPLETED ·Phase: PHASE3
-
SOURCE 3: Observational Study to Evaluate Safety and Performance of SAPIEN 3 THV System in Real Life Practice
NCT02698956 ·Status: COMPLETED
-
Disrupt CAD III Post-Approval Study (PAS)
NCT05021757 ·Status: COMPLETED
-
BeGrow Study to Treat Pulmonary Artery (PA) Stenosis in Newborns and Infants
NCT03287024 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA